RSPH:NYE-Invesco S&P 500 Equal Weight Health Care ETF (USD)

ETF | Others |

Last Closing

USD 29.62

Change

0.00 (0.00)%

Market Cap

USD 0.88B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.17 (-0.90%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.04 (+0.07%)

USD 37.61B
DFAC Dimensional U.S. Core Equity 2..

+0.05 (+0.14%)

USD 33.40B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 28.50B
JPST JPMorgan Ultra-Short Income ET..

+0.02 (+0.04%)

USD 28.13B
DTB DTE Energy Company 2020 Series

-0.20 (-1.05%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-2.69 (-3.43%)

USD 21.47B
JAAA Janus Detroit Street Trust - J..

+0.03 (+0.06%)

USD 16.06B
AVUV Avantis® U.S. Small Cap Value..

+0.54 (+0.56%)

USD 15.95B
DFUS Dimensional U.S. Equity ETF

+0.06 (+0.09%)

USD 13.15B

ETFs Containing RSPH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.54% 26% F 36% F
Dividend Return 0.51% 6% D- 6% D-
Total Return -0.03% 11% F 25% F
Trailing 12 Months  
Capital Gain -0.64% 28% F 36% F
Dividend Return 0.51% 6% D- 5% F
Total Return -0.13% 16% F 27% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -4.88% 11% F 12% F
Dividend Return -4.72% 9% A- 9% A-
Total Return 0.16% 14% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 24.75% 12% F 45% F
Risk Adjusted Return -19.07% 15% F 11% F
Market Capitalization 0.88B 88% B+ 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.